| 1 |
33579790 |
10.1136/gutjnl-2020-322935 |
2022 |
Oncogenetic landscape of lymphomagenesis in coeliac disease. |
KMT2D |
| 2 |
34265801 |
10.1097/PAS.0000000000001780 |
2022 |
Plasticity of Mature B Cells Between Follicular and Classic Hodgkin Lymphomas: A Series of 22 Cases Expanding the Spectrum of Transdifferentiation. |
KMT2D |
| 3 |
34325497 |
10.4143/crt.2021.752 |
2022 |
Plasma Circulating Tumor DNA in Patients with Primary Central Nervous System Lymphoma. |
KMT2D |
| 4 |
34494161 |
10.1007/s00428-021-03186-3 |
2022 |
Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin. |
KMT2D |
| 5 |
34515044 |
10.1159/000518227 |
2022 |
A Patient with Kabuki Syndrome Mutation Presenting with Very Severe Aplastic Anemia. |
KMT2D |
| 6 |
34553842 |
10.1002/cnr2.1559 |
2022 |
Genetic features of B-cell lymphoblastic lymphoma with TCF3-PBX1. |
KMT2D |
| 7 |
34601504 |
10.1038/s41379-021-00938-z |
2022 |
Histopathologic, immunophenotypic, and mutational landscape of follicular lymphomas with plasmacytic differentiation. |
KMT2D |
| 8 |
34654055 |
10.1182/bloodadvances.2021006034 |
2022 |
Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements. |
KMT2D |
| 9 |
34664256 |
10.1111/bjh.17894 |
2022 |
Tracking the evolution of untreated high-intermediate/high-risk diffuse large B-cell lymphoma by circulating tumour DNA. |
KMT2D |
| 10 |
34837284 |
10.1111/cas.15224 |
2022 |
Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma. |
KMT2D |
| 11 |
34957565 |
10.1002/path.5861 |
2022 |
Widespread in situ follicular neoplasia in patients who subsequently developed follicular lymphoma. |
KMT2D |
| 12 |
34967008 |
10.1111/bjh.17990 |
2022 |
The molecular ontogeny of follicular lymphoma: gene mutations succeeding the BCL2 translocation define common precursor cells. |
KMT2D |
| 13 |
34977845 |
10.1016/j.xjidi.2021.100068 |
2022 |
Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders. |
KMT2D |
| 14 |
34980601 |
10.1158/1078-0432.CCR-21-2949 |
2022 |
Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma. |
KMT2D |
| 15 |
35022084 |
10.1186/s13046-021-02234-9 |
2022 |
The follicular lymphoma epigenome regulates its microenvironment. |
KMT2D |
| 16 |
35038193 |
10.1111/his.14617 |
2022 |
Incidence, clinicopathological features and genetics of in-situ follicular neoplasia: a comprehensive screening study in a Japanese cohort. |
KMT2D |
| 17 |
35045798 |
10.1080/10428194.2021.2024821 |
2022 |
High grade B-cell lymphoma with <i>MYC</i>, <i>BCL2</i> and/or <i>BCL6</i> rearrangements: unraveling the genetic landscape of a rare aggressive subtype of non-Hodgkin lymphoma. |
KMT2D |
| 18 |
35240014 |
10.4143/crt.2022.017 |
2022 |
Circulating Tumor DNA-Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas. |
KMT2D |
| 19 |
35266562 |
10.1002/ajh.26523 |
2022 |
Mantle cell lymphoma in 2022-A comprehensive update on molecular pathogenesis, risk stratification, clinical approach, and current and novel treatments. |
KMT2D |
| 20 |
35300216 |
10.2147/JIR.S341355 |
2022 |
The Mutation of <i>BTG2</i> Gene Predicts a Poor Outcome in Primary Testicular Diffuse Large B-Cell Lymphoma. |
KMT2D |
| 21 |
35317330 |
10.14740/wjon1436 |
2022 |
Non-GCB Diffuse Large B-Cell Lymphoma With an Atypical Disease Course: A Case Report and Clinical Exome Analysis. |
KMT2D |
| 22 |
35363872 |
10.1182/bloodadvances.2021005284 |
2022 |
Molecular subclusters of follicular lymphoma: a report from the UK's Haematological Malignancy Research Network. |
KMT2D |
| 23 |
35411950 |
10.1002/cbf.3702 |
2022 |
USP7 sustains an active epigenetic program via stabilizing MLL2 and WDR5 in diffuse large B-cell lymphoma. |
KMT2D |
| 24 |
35522148 |
10.3324/haematol.2021.280005 |
2022 |
Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase <i>KDM4C</i> in B cell lymphomas. |
KMT2D |
| 25 |
35646048 |
10.3389/fgene.2022.878618 |
2022 |
Whole-Genome/Exome Sequencing Uncovers Mutations and Copy Number Variations in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System. |
KMT2D |
| 26 |
35816682 |
10.1182/bloodadvances.2022008355 |
2022 |
Genomic and microenvironmental landscape of stage I follicular lymphoma, compared to stage III/IV. |
KMT2D |
| 27 |
35879731 |
10.1186/s40364-022-00401-4 |
2022 |
Dynamic change of soluble interleukin-2 receptor distinguished molecular heterogeneity and microenvironment alterations in diffuse large B-cell lymphoma. |
KMT2D |
| 28 |
35882439 |
10.1182/bloodadvances.2022007541 |
2022 |
Genetic and immunohistochemical profiling of NK/T-cell Lymphomas reveals prognostically relevant BCOR-MYC association. |
KMT2D |
| 29 |
35908982 |
10.1016/j.blre.2022.100992 |
2022 |
Follicular lymphoma: The long and winding road leading to your cure? |
KMT2D |
| 30 |
35937947 |
10.1155/2022/6441139 |
2022 |
Genomic Mutation Landscape of Primary Breast Lymphoma: Next-Generation Sequencing Analysis. |
KMT2D |
| 31 |
36048893 |
10.1093/ajcp/aqac104 |
2022 |
Systemic Presentation of Somatic TET2 Mutated B-Cell Lymphoma in a Child With Kabuki Syndrome and a Germline KMT2D Variant. |
KMT2D |
| 32 |
36055572 |
10.1016/j.clim.2022.109105 |
2022 |
A novel immune-related epigenetic signature based on the transcriptome for predicting the prognosis and therapeutic response of patients with diffuse large B-cell lymphoma. |
KMT2D |
| 33 |
36081566 |
10.3389/fonc.2022.941347 |
2022 |
Molecular subtyping of CD5+ diffuse large B-cell lymphoma based on DNA-targeted sequencing and Lymph2Cx. |
KMT2D |
| 34 |
32855278 |
10.3324/haematol.2020.254854 |
2021 |
Genetic evolution of <i>in situ</i> follicular neoplasia to aggressive B-cell lymphoma of germinal center subtype. |
KMT2D |
| 35 |
32929178 |
10.1038/s41379-020-00673-x |
2021 |
The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy. |
KMT2D |
| 36 |
32973328 |
10.1038/s41379-020-00685-7 |
2021 |
The clinicopathological and molecular features of sinusoidal large B-cell lymphoma. |
KMT2D |
| 37 |
33152759 |
10.1182/blood.2020005381 |
2021 |
Integrative genomic analysis of pediatric T-cell lymphoblastic lymphoma reveals candidates of clinical significance. |
KMT2D |
| 38 |
33413063 |
10.2174/1568009620666210106122750 |
2021 |
Epigenetic Mechanisms of Therapy Resistance in Diffuse Large B Cell Lymphoma (DLBCL). |
KMT2D |
| 39 |
33431788 |
10.1038/s41392-020-00437-8 |
2021 |
CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis. |
KMT2D |
| 40 |
33432228 |
10.1038/s41590-020-00827-8 |
2021 |
Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation. |
KMT2D |
| 41 |
33479306 |
10.1038/s41598-020-80376-0 |
2021 |
Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma. |
KMT2D |
| 42 |
33544565 |
10.1097/PAS.0000000000001658 |
2021 |
Immunophenotypic Spectrum and Genomic Landscape of Refractory Celiac Disease Type II. |
KMT2D |
| 43 |
33560380 |
10.1182/bloodadvances.2020002469 |
2021 |
Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features. |
KMT2D |
| 44 |
33562694 |
10.3390/cancers13040641 |
2021 |
Follicular Lymphoma Microenvironment: An Intricate Network Ready for Therapeutic Intervention. |
KMT2D |
| 45 |
33581493 |
10.1016/j.ctarc.2021.100310 |
2021 |
Diversity of genetic alterations of primary central nervous system lymphoma in Hispanic versus non-Hispanic patients. |
KMT2D |
| 46 |
33747936 |
10.3389/fonc.2021.622648 |
2021 |
Genomic Mutation Profile of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma. |
KMT2D |
| 47 |
33786580 |
10.1182/blood.2020008743 |
2021 |
KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas. |
KMT2D |
| 48 |
33809641 |
10.3390/cancers13061340 |
2021 |
Detection of Rare Germline Variants in the Genomes of Patients with B-Cell Neoplasms. |
KMT2D |
| 49 |
33829512 |
10.1111/his.14378 |
2021 |
Bcl-2-negative IGH-BCL2 translocation-negative follicular lymphoma of the thyroid differs genetically and epigenetically from Bcl-2-positive IGH-BCL2 translocation-positive follicular lymphoma. |
KMT2D |
| 50 |
33939500 |
10.1177/10668969211013402 |
2021 |
A Pedigree Analysis and Clonal Correlations of the Coexistence of B-Cell Lymphoma and Histiocytic/Dendritic Cell Tumor. |
KMT2D |
| 51 |
33945543 |
10.1371/journal.pone.0248886 |
2021 |
Detection of new drivers of frequent B-cell lymphoid neoplasms using an integrated analysis of whole genomes. |
KMT2D |
| 52 |
33964277 |
10.1016/j.humpath.2021.04.014 |
2021 |
Relative frequency and clinicopathologic characteristics of MYC-rearranged follicular lymphoma. |
KMT2D |
| 53 |
34039950 |
10.1038/s41408-021-00493-5 |
2021 |
Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing. |
KMT2D |
| 54 |
34080947 |
10.1080/10428194.2021.1933480 |
2021 |
Targeted genomic investigations in a population-based cohort of mantle cell lymphoma reveal novel clinically relevant targets. |
KMT2D |
| 55 |
34256839 |
10.1186/s40164-021-00232-3 |
2021 |
Progress in molecular feature of smoldering mantle cell lymphoma. |
KMT2D |
| 56 |
34334687 |
10.1097/PAS.0000000000001726 |
2021 |
High-grade Follicular Lymphomas Exhibit Clinicopathologic, Cytogenetic, and Molecular Diversity Extending Beyond Grades 3A and 3B. |
KMT2D |
| 57 |
34350060 |
10.1080/2162402X.2021.1928365 |
2021 |
Genomic complexity is associated with epigenetic regulator mutations and poor prognosis in diffuse large B-cell lymphoma. |
KMT2D |
| 58 |
34535012 |
10.1182/bloodadvances.2021004562 |
2021 |
Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations. |
KMT2D |
| 59 |
34558064 |
10.1111/bjh.17824 |
2021 |
Retrospective analyses of other iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with rheumatic diseases. |
KMT2D |
| 60 |
34570179 |
10.1182/bloodadvances.2021004668 |
2021 |
Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies. |
KMT2D |
| 61 |
34590470 |
10.52586/4970 |
2021 |
Methylation alterations and advance of treatment in lymphoma. |
KMT2D |
| 62 |
34621263 |
10.3389/fimmu.2021.688493 |
2021 |
Cohesin Core Complex Gene Dosage Contributes to Germinal Center Derived Lymphoma Phenotypes and Outcomes. |
KMT2D |
| 63 |
34671837 |
10.1007/s00292-021-01011-x |
2021 |
[Genetic evolution of in situ follicular neoplasia to t(14;18)-positive aggressive B-cell lymphoma]. |
KMT2D |
| 64 |
34745101 |
10.3389/fimmu.2021.732006 |
2021 |
International Prognostic Index-Based Immune Prognostic Model for Diffuse Large B-Cell Lymphoma. |
KMT2D |
| 65 |
34925435 |
10.3389/fgene.2021.677650 |
2021 |
Genetic Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma: A Systemic Review and Association Analysis With Next-Generation Sequencing. |
KMT2D |
| 66 |
35008340 |
10.3390/cancers14010176 |
2021 |
Recent Advances in the Genetic of MALT Lymphomas. |
KMT2D |
| 67 |
35071240 |
10.3389/fcell.2021.805195 |
2021 |
Epigenetic, Metabolic, and Immune Crosstalk in Germinal-Center-Derived B-Cell Lymphomas: Unveiling New Vulnerabilities for Rational Combination Therapies. |
KMT2D |
| 68 |
35846093 |
10.1002/jha2.131 |
2021 |
Liquid biopsy for disease monitoring after anti-CD19 chimeric antigen receptor T cell in diffuse large B-cell lymphoma. |
KMT2D |
| 69 |
31028364 |
10.1038/s41379-019-0279-8 |
2020 |
Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified. |
KMT2D |
| 70 |
31537689 |
10.3324/haematol.2018.214056 |
2020 |
<i>KMT2D</i> mutations and <i>TP53</i> disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study. |
KMT2D |
| 71 |
31705772 |
10.1002/gcc.22825 |
2020 |
Molecular characteristics of terminal deoxynucleotidyl transferase negative precursor B-cell phenotype Burkitt leukemia with IGH-MYC rearrangement. |
KMT2D |
| 72 |
31738823 |
10.1182/blood.2019002699 |
2020 |
Distinct molecular profile of IRF4-rearranged large B-cell lymphoma. |
KMT2D |
| 73 |
31752573 |
10.1080/10428194.2019.1691200 |
2020 |
New murine models of aggressive lymphoma. |
KMT2D |
| 74 |
31774495 |
10.1182/blood.2019001904 |
2020 |
Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL. |
KMT2D |
| 75 |
31776129 |
10.1101/mcs.a004614 |
2020 |
Dramatic increase in gene mutational burden after transformation of follicular lymphoma into TdT<sup>+</sup> B-lymphoblastic leukemia/lymphoma. |
KMT2D |
| 76 |
31807922 |
10.1007/s00428-019-02691-w |
2020 |
Subsequent development of histiocytic sarcoma and follicular lymphoma: cytogenetics and next-generation sequencing analyses provide evidence for transdifferentiation of early common lymphoid precursor-a case report and review of literature. |
KMT2D |
| 77 |
31886867 |
10.1093/jnen/nlz125 |
2020 |
Molecular Subtypes and Genomic Profile of Primary Central Nervous System Lymphoma. |
KMT2D |
| 78 |
31980558 |
10.1136/jclinpath-2019-206282 |
2020 |
Diagnostic value of bone marrow core biopsy patterns in lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia and description of its mutational profiles by targeted NGS. |
KMT2D |
| 79 |
32010998 |
10.1002/hon.2720 |
2020 |
Refractory celiac disease type II: An atypical case highlighting limitations of the current classification system. |
KMT2D |
| 80 |
32012328 |
10.1002/hon.2718 |
2020 |
High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas. |
KMT2D |
| 81 |
32064880 |
10.4149/neo_2020_190307N194 |
2020 |
KMT2D and TP53 mutation status improve the prognostic value of the International Prognostic Index (IPI) stratification in ENKTL patients. |
KMT2D |
| 82 |
32127923 |
10.1177/1758835919900856 |
2020 |
Epigenetic aberrations in natural killer/T-cell lymphoma: diagnostic, prognostic and therapeutic implications. |
KMT2D |
| 83 |
32239385 |
10.1007/s11523-020-00710-4 |
2020 |
Genomic Alterations and MYD88<sup>MUT</sup> Variant Mapping in Patients with Diffuse Large B-Cell Lymphoma and Response to Ibrutinib. |
KMT2D |
| 84 |
32239765 |
10.1002/ajh.25796 |
2020 |
Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients. |
KMT2D |
| 85 |
32350066 |
10.1158/0008-5472.CAN-19-2247 |
2020 |
FBXW7 Triggers Degradation of KMT2D to Favor Growth of Diffuse Large B-cell Lymphoma Cells. |
KMT2D |
| 86 |
32399964 |
10.1002/ijc.33049 |
2020 |
Molecular profiling of Chinese R-CHOP treated DLBCL patients: Identifying a high-risk subgroup. |
KMT2D |
| 87 |
32459397 |
10.1111/jcmm.15425 |
2020 |
Establishment and characterization of a novel 'double-hit' follicular lymphoma cell line, FL-SJC. |
KMT2D |
| 88 |
32469082 |
10.1002/cncr.32866 |
2020 |
Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphoma. |
KMT2D |
| 89 |
32589730 |
10.1182/bloodadvances.2020001696 |
2020 |
Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma. |
KMT2D |
| 90 |
32695399 |
10.1186/s40364-020-00205-4 |
2020 |
Plasma circulating tumor DNA assessment reveals <i>KMT2D</i> as a potential poor prognostic factor in extranodal NK/T-cell lymphoma. |
KMT2D |
| 91 |
32770099 |
10.1038/s41598-020-70310-9 |
2020 |
Genetic heterogeneity and prognostic impact of recurrent ANK2 and TP53 mutations in mantle cell lymphoma: a multi-centre cohort study. |
KMT2D |
| 92 |
32871937 |
10.1097/MD.0000000000021938 |
2020 |
Aggressive variant of splenic marginal zone lymphoma characterized using a cancer panel test and treated with rituximab-containing chemotherapy: A case report. |
KMT2D |
| 93 |
33045225 |
10.1016/j.humpath.2020.09.014 |
2020 |
The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma. |
KMT2D |
| 94 |
33188997 |
10.1016/j.ctarc.2020.100235 |
2020 |
Activity of ibrutinib plus R-CHOP in diffuse large B-cell lymphoma: Response, pharmacodynamic, and biomarker analyses of a phase Ib study. |
KMT2D |
| 95 |
33211828 |
10.1182/bloodadvances.2020002944 |
2020 |
Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease. |
KMT2D |
| 96 |
33376237 |
10.1038/s41392-020-00331-3 |
2020 |
Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma. |
KMT2D |
| 97 |
29629950 |
10.1097/PAI.0000000000000644 |
2019 |
A Survey of Somatic Mutations in 41 Genes in a Cohort of T-Cell Lymphomas Identifies Frequent Mutations in Genes Involved in Epigenetic Modification. |
KMT2D |
| 98 |
30282051 |
10.1016/j.clim.2018.09.013 |
2019 |
Exome sequencing confirms diagnosis of kabuki syndrome in an-adult with hodgkin lymphoma and unusually severe multisystem phenotype. |
KMT2D |
| 99 |
30567752 |
10.1182/blood-2018-07-864025 |
2019 |
The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma. |
KMT2D |
| 100 |
30569626 |
10.1002/ajmg.a.60674 |
2019 |
Burkitt lymphoma in a patient with Kabuki syndrome carrying a novel KMT2D mutation. |
KMT2D |
Datasets
Models
